More favorable clinical course in kidney allograft recipients due to HLA-B+ DR matching.
Department of Internal Medicine, University Hospital, Maastricht, The Netherlands.
M H
MH
Christiaans
P M
PM
van den Berg-Loonen
H G
HG
Peltenburg
K M
KM
Leunissen
J P
JP
van Hooff
D002102:Cadaver; D005500:Follow-Up Studies; D006084:Graft Rejection; D015235:HLA-B Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000502:physiology*; D015999:Multivariate Analysis; D016896:Treatment Outcome
D015235:HLA-B Antigens; D006684:HLA-DR Antigens